
Opinion|Videos|September 27, 2024
Treatment Landscape for Transplant-Eligible Patients with NDMM
Panelists discuss how the current first-line treatment options for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM) typically involve combination therapies including proteasome inhibitors, immunomodulatory drugs, and steroids.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Provide a brief overview of first-line treatment options currently available for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
Sonrotoclax Plus Zanubrutinib Produces Deep MRD Responses in Treatment-Naive CLL
4
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
5
































































































































